Irinotecan, Carboplatin and Radiation Therapy Followed by Bevacizumab in Limited Stage Small Cell Lung Cancer

NCT00193375 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: Irinotecan
DRUG: Carboplatin
DRUG: Bevacizumab
RADIATION: Radiation

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]
[object Object]